A danger of induction of Brugada syndrome during pill-in-the-pocket therapy for paroxysmal atrial fibrillation

Yoshiyasu Aizawa, Tomohiro Matsuhashi, Toshiaki Sato, Seiji Takatsuki, Keiichi Fukuda

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Rhythm control therapy by sodium channel blockers is widely performed for the treatment of paroxysmal atrial fibrillation. Here, we present a case of acquired Brugada syndrome by pill-in-the-pocket treatment using pilsicainide. It is important that this therapy should be applied only after confirming the drug safety to the patients.

Original languageEnglish
Pages (from-to)139-140
Number of pages2
JournalDrug, Healthcare and Patient Safety
Volume2
Issue number1
DOIs
Publication statusPublished - 2010 Oct 1

Keywords

  • Atrial flutter
  • Drug
  • Pilsicainide
  • Rhythm control
  • Sudden death
  • Syncope

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy

Fingerprint Dive into the research topics of 'A danger of induction of Brugada syndrome during pill-in-the-pocket therapy for paroxysmal atrial fibrillation'. Together they form a unique fingerprint.

  • Cite this